Urinary Diversion/Reconstruction for Cases of Catheter Intolerant Secondary Progressive Multiple Sclerosis With Refractory Urinary Symptoms
Abstract
Purpose:
We assessed surgical outcomes for patients intolerant of catheters with secondary progressive multiple sclerosis undergoing urinary diversion/reconstruction for refractory urinary symptoms.
Materials and Methods:
Patients with secondary progressive multiple sclerosis treated with ileovesicostomy, enterocystoplasty and ileal loop surgeries were reviewed for demographic, operative and postoperative data. All patients had attempted maximal conservative therapy, including catheterization options. Evaluated outcome measures included incidence of postoperative urinary incontinence, urinary tract infections and Clavien grade 3 or higher complications.
Results:
A total of 26 patients (22 female) with secondary progressive multiple sclerosis underwent 15 ileovesicostomy, 7 enterocystoplasty and 4 ileal loop procedures. All patients had significant neurological impairment (mean Expanded Disability Status Scale 7), and the most common indications for surgery were chronic urinary tract infection (77%) and refractory incontinence (77%). Maximum preoperative bladder capacity was 185 cc and mean bladder compliance was 5.7 cc/cm H2O. After a mean followup of 16 months 63% of patients were continent (p = 0.01) and 58% had no further urinary tract infections (p = 0.03). The type of diversion/reconstruction was not associated with significantly improved continence or urinary tract infection reduction. No new upper tract changes developed in any patients. There were 11 high grade complications, and patients with a preoperative indwelling catheter (HR 5.89, p = 0.024), diabetes (HR 5.60, p = 0.009) and increasing blood loss during surgery (HR 1.09, p = 0.014) were at greatest risk for significant complications.
Conclusions:
Patients with secondary progressive multiple sclerosis treated with urinary diversion/reconstruction who cannot tolerate catheters had improved continence and fewer urinary tract infections. However, patients with secondary progressive multiple sclerosis with preoperative indwelling catheters, diabetes, increased body mass index and increasing operative blood loss were at greatest risk for postoperative morbidity.
References
- 1 : Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci2008; 29: S352. Google Scholar
- 2 : Multiple sclerosis and the urologist. J Urol1999; 161: 743. Link, Google Scholar
- 3 : Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends Neurosci2010; 33: 202. Google Scholar
- 4 : A UK consensus on the management of the bladder in multiple sclerosis. Postgrad Med J2009; 85: 552. Google Scholar
- 5 : Augmentation cystoplasty in patients with multiple sclerosis. Urol Int2003; 70: 21. Google Scholar
- 6 : The results of urinary diversion in multiple sclerosis. Br J Urol1977; 49: 495. Google Scholar
- 7 : Ileovesicostomy for adults with neurogenic bladders: complications and potential risk factors for adverse outcomes. Neurourol Urodyn2008; 27: 238. Google Scholar
- 8 : Neurogenic bladder management and cutaneous non-continent ileal conduit. Spinal Cord2002; 40: 443. Google Scholar
- 9 : An expert system for the evaluation of EDSS in multiple sclerosis. Artif Intell Med2002; 25: 187. Google Scholar
- 10 : Relapses and progression of disability in multiple sclerosis. N Engl J Med2000; 343: 1430. Google Scholar
- 11 : Long-term outcome of incontinent ileovesicostomy management of severe lower urinary tract dysfunction. J Urol1999; 161: 1803. Link, Google Scholar
- 12 : Enterocystoplasty or detrusor myectomy?: Comparison of indications and outcomes for bladder augmentation . J Urol1999; 161: 758. Link, Google Scholar
- 13 : Technique of uretero-ileal-cutaneous anastomosis (“the Ileal Loop”). Surg Clin North Am1965; 45: 741. Google Scholar
- 14 : The Boari bladder flap: an effective continent stoma for the high-compliance neurogenic bladder. BJU Int2010; 105: 1291. Google Scholar
- 15 : The Mitrofanoff principle: Technique and application in continent urinary diversion . Urol Clin North Am1991; 18: 615. Google Scholar
- 16 : Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg2004; 240: 205. Google Scholar
- 17 : The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler2007; 13: 915. Google Scholar
- 18 : Laparoscopic cystectomy and transileal ureterostomy for neurogenic vesicosphincteric disorders: Evaluation of morbidity . Prog Urol2007; 17: 208. Google Scholar
- 19 : Bladder neck closure with continent augmentation or suprapubic catheter in patients with neurogenic bladders. J Am Paraplegia Soc1993; 16: 18. Google Scholar
- 20 : Incontinent ileovesicostomy: long-term outcomes and complications. Neurourol Urodyn2009; 28: 483. Google Scholar
- 21 : Neurological symptoms accompanying urinary tract infections. Eur Neurol2010; 63: 180. Google Scholar
- 22 : 15 Years of continent urinary diversion and enterocystoplasty in children and adolescents: the Würzburg experience. BJU Int2010; 105: 698. Google Scholar
- 23 : Urethral versus suprapubic catheter: choosing the best bladder management for male spinal cord injury patients with indwelling catheters. Spinal Cord2010; 48: 325. Google Scholar
- 24 : Surgical apgar outcome score: perioperative risk assessment for radical cystectomy. J Urol2009; 181: 1046. Link, Google Scholar
- 25 : Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol2010; 183: 929. Link, Google Scholar
- 26 : Urinary diversion and orthotopic bladder substitution in children and young adults with neurogenic bladder: a safe option for treatment?. J Urol2000; 163: 568. Link, Google Scholar
- 27 : Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev2003; 1. CD003306. Google Scholar
- 28 : Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol2007; 62: 452. Google Scholar
- 29 : Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol2008; 53: 613. Google Scholar
- 30 : Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects. J Spinal Cord Med2008; 31: 157. Google Scholar
